NCT02618304View on ClinicalTrials.gov

Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 20, 2015

Primary Completion Date

February 19, 2016

Study Completion Date

February 19, 2016

Conditions
Meibomian Gland Dysfunction
Interventions
DRUG

Treatment of Meibomian gland dysfunction

artificial tears, 3% Diquafosol Tetrasodium eye drops, steroid eye drops, squeezing of meibomian glands, cleansing of eyelids.

Trial Locations (1)

03722

Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02618304 - Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter